Baltimore, MD, United States of America

Richard A Cone

This inventor holds 21 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 4 EPO patents, primarily in Microbial Infection Control. Top assignees: Johns Hopkins University, The University of North Carolina at Chapel Hill, Reprotect, Inc.. Active years: 1997-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard A Cone. Retrieved from https://idiyas.com/inventor/richard-a-cone

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 90.5


 

Average Co-Inventor Count = 3.3

ph-index = 7

Forward Citations = 130(Granted Patents)


Company Filing History:


Years Active: 1997-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Bacterial Vaginosis
Microbicidal Formulations
Nanoparticle Delivery
Intravaginal Devices
Mucosal Penetration
Pathogen Inhibition
Topical Antibodies
Active Agent Transport
Acidic Buffering
Cervical Delivery
Hydrogel Formulations
Simultaneous Delivery
21 patents (USPTO):Explore Patents

Title: Richard A. Cone: A Pioneer in Innovative Medical Patents

Introduction

Richard A. Cone, based in Baltimore, MD, is an accomplished inventor with a remarkable portfolio of 21 patents. His work primarily focuses on advancements in medical treatments, particularly relating to women's health and respiratory infections. Cone's innovative approach to utilizing cervicovaginal secretions and developing antiviral compositions has made significant contributions to medical science.

Latest Patents

Two of Cone's latest patents address critical health issues. The first patent involves "CVS transplantation for treatment of bacterial vaginosis." This innovation provides methods and materials for treating bacterial vaginosis by transplanting cervicovaginal secretions from a healthy donor to women afflicted with this condition. By restoring beneficial vaginal microbial communities, this technique enhances the women's resistance to sexually transmitted diseases. Furthermore, the efficacy of this method can be improved by administering an acidifying agent, such as lactic acid, which can enhance the properties of the endogenous cervical secretions.

The second patent, "Compositions and methods for inhibiting pathogen infection," focuses on respiratory health. It involves novel antibodies and compositions designed to inhibit and treat viral infections within the respiratory tract. By trapping viruses in the mucus secretions of the respiratory system, this innovative approach restricts viral transmission and offers new avenues for treatment.

Career Highlights

Throughout his career, Richard A. Cone has been associated with esteemed institutions such as The Johns Hopkins University. His efforts have consistently centered around advancing medical knowledge and developing practical applications that benefit patients and healthcare providers.

Collaborations

Cone has collaborated with notable coworkers, including Laura M. Ensign and Justin Scot Hanes. These partnerships have further enriched his research and innovations, allowing for cross-disciplinary approaches to complex medical challenges.

Conclusion

In summary, Richard A. Cone stands out as a leading inventor whose patents address significant health concerns, specifically in women's health and viral infections. His commitment to innovation through research and collaboration with fellow experts has established him as an influential figure in the realm of medical inventions. As he continues to push the boundaries of scientific exploration, his work is likely to inspire future developments in healthcare technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…